SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001561743-18-000073
Filing Date
2018-07-24
Accepted
2018-07-24 16:12:41
Documents
6
Effectiveness Date
2018-07-24

Document Format Files

Seq Description Document Type Size
1 S-8 s-8july2018equityincentive.htm S-8 93737
2 TG OPINION exhibit51tgopinion.htm EX-5.1 19224
3 AUDITOR CONSENT exhibit231july2018s-8audit.htm EX-23.1 2809
4 FORM OF STOCK OPTION GRANT exhibit993stockoptiongrant.htm EX-99.3 79075
5 FORM OF RESTRICTED STOCK GRANT exhibit994restrictedstocka.htm EX-99.4 50421
6 FORM OF RESTRICTED UNIT GRANT exhibit995restrictedstocku.htm EX-99.5 48982
  Complete submission text file 0001561743-18-000073.txt   295244
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-226321 | Film No.: 18966661
SIC: 2834 Pharmaceutical Preparations